Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

General Description

Altimmune

Youtube Subscribe

...

Ticker: ALT

Sector: Biotechnology

Altimmune, Inc. focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, is in Phase 2 trial for obesity. It is also developing HepTcell, an immunother.
...
...
Extended Summary

Altimmune

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and non-alcoholic steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.

Related Results

...
October 17, 2023 13:44 (London Time)

Altimmune

Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. State Street Corp lifted its s…
Sector: Biotechnology
Ticker: ALT
Sentiment: 0.9455
MarketCap: 145,151,103.0
High: 2.86 Low: 2.73

Open: 2.68 Close: 2.81 Change: 0.13

Read more →
...
May 09, 2023 19:07 (London Time)

Altimmune

Altimmune (NASDAQ: ALT) stock is losing value on Tuesday after the company released results from a clinical trial. Altimmune is constantly working o…
Sector: Biotechnology
Ticker: ALT
Sentiment: 0.9686
MarketCap: 522.95M
High: 5.04 Low: 4.79

Open: 4.91 Close: 4.99 Change: 0.09

Read more →
...
September 27, 2023 21:51 (London Time)

Altimmune

Altimmune announces oral presentation of pemvidutide clinical. data at 59th Annual Meeting of European Association for the Study of Diabetes. Altimm…
Sector: Biotechnology
Ticker: ALT
Sentiment: 0.4588
MarketCap: 132,769,793.0
High: 2.59 Low: 2.51

Open: 2.53 Close: 2.52 Change: -0.01

Read more →
Search
Happening Now
Categories